| Gene symbol | IL3RA | Synonyms | CD123, IL-3R-alpha, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra | Type of gene | protein-coding |
| Chromosome | X|Y | Map location | X;Y | dbXrefs | |
| Description | interleukin 3 receptor subunit alpha | ||||
| GTO ID | GTC3564 |
| Trial ID | NCT06006403 |
| Disease | Blastic Plasmacytoid Dendritic Cell Neoplasm | Acute Myeloid Leukemia |
| Altered gene | CD123 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | CD123 CAR-NK cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm |
| Year | 2023 |
| Country | China |
| Company sponsor | Chongqing Precision Biotech Co., Ltd |
| Other ID(s) | PBC050 |
| Cohort 1 | |||||||||||
|
|||||||||||